Intelligent Bio Solutions (INBS, Financial) has successfully conducted a high-volume drug testing for the workforce of Barcaldine Regional Council in Queensland, Australia, utilizing its innovative Intelligent Fingerprinting Drug Screening System. This achievement marks a significant step in INBS's strategy to penetrate regional and remote workforce testing markets.
The testing process, which screened over 160 employees or 100% of the workforce, was completed in less than 90 minutes. This rapid and efficient operation ensured all employees were declared fit for duty by the start of their workday, while causing minimal disturbance to ongoing business activities.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Intelligent Bio Solutions Inc (INBS, Financial) is $12.00 with a high estimate of $12.00 and a low estimate of $12.00. The average target implies an upside of 883.61% from the current price of $1.22. More detailed estimate data can be found on the Intelligent Bio Solutions Inc (INBS) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Intelligent Bio Solutions Inc's (INBS, Financial) average brokerage recommendation is currently 1.0, indicating "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
